Clinical Trial Imaging Market Analysis, Trends & Forecast - 2032

Clinical Trial Imaging Market Size - By Service (Clinical Trial Design & Consultation Services), Imaging Technique, Therapeutic Area, End-user, Global Forecast 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast Calculation

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Clinical trial imaging industry 360&ordm; synopsis, 2018 &ndash; 2032 (USD Million)

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Service trends

2.1.4&nbsp;&nbsp;&nbsp; Imaging technique trends

2.1.5&nbsp;&nbsp;&nbsp; Therapeutic area trends

2.1.6&nbsp;&nbsp;&nbsp; End user trends

Chapter 3&nbsp;&nbsp;&nbsp;Clinical Trial Imaging Market Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032 (USD Million)

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Growing number of clinical studies

3.2.1.2&nbsp;&nbsp;&nbsp;Increasing number of contract research organizations (CROS)

3.2.1.3&nbsp;&nbsp;&nbsp;Rise in R&amp;D expenditure

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Clinical study expenses

3.2.2.2&nbsp;&nbsp;&nbsp;High cost associated with the imaging techniques and potential exposure to radiation

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By service

3.3.2&nbsp;&nbsp;&nbsp; By imaging technique

3.3.3&nbsp;&nbsp;&nbsp; By therapeutic area

3.3.4&nbsp;&nbsp;&nbsp; By end user

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Clinical Trial Imaging Market Estimates and Forecast, By Service, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by service

5.2&nbsp;&nbsp;&nbsp; Clinical trial design and consultation services

5.3&nbsp;&nbsp;&nbsp; Reading and analytical services

5.4&nbsp;&nbsp;&nbsp; Operational imaging

5.5&nbsp;&nbsp;&nbsp; System and technology support services

5.6&nbsp;&nbsp;&nbsp; Project and data management

Chapter 6&nbsp;&nbsp;&nbsp;Clinical Trial Imaging Market Estimates and Forecast, By Imaging Techniques, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by imaging technique

6.2&nbsp;&nbsp;&nbsp; Magnetic resonance imaging (MRI)

6.3&nbsp;&nbsp;&nbsp; Computed tomography (CT) scan

6.4&nbsp;&nbsp;&nbsp; Ultrasound

6.5&nbsp;&nbsp;&nbsp; Positron emission tomography (PET)

6.6&nbsp;&nbsp;&nbsp; Echocardiography (ECG)

6.7&nbsp;&nbsp;&nbsp; X-ray

6.8&nbsp;&nbsp;&nbsp; Other imaging techniques

Chapter 7&nbsp;&nbsp;&nbsp;Clinical Trial Imaging Market Estimates and Forecast, By Therapeutic Area, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by therapeutic area

7.2&nbsp;&nbsp;&nbsp; Central nervous system

7.3&nbsp;&nbsp;&nbsp; Oncology

7.4&nbsp;&nbsp;&nbsp; Infectious disease

7.5&nbsp;&nbsp;&nbsp; Endocrinology &amp; metabolic disorders

7.6&nbsp;&nbsp;&nbsp; Diabetes

7.7&nbsp;&nbsp;&nbsp; Musculoskeletal

7.8&nbsp;&nbsp;&nbsp; Cardiovascular diseases

7.9&nbsp;&nbsp;&nbsp; Respiratory

7.10&nbsp;&nbsp;&nbsp; Gastroenterology

7.11&nbsp;&nbsp;&nbsp; Nonalcoholic steatohepatitis (NASH)

7.12&nbsp;&nbsp;&nbsp; Other therapeutic areas

Chapter 8&nbsp;&nbsp;&nbsp;Clinical Trial Imaging Market Estimates and Forecast, By End User, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by end user

8.2&nbsp;&nbsp;&nbsp; Biotechnology and pharmaceutical companies

8.3&nbsp;&nbsp;&nbsp; Medical devices manufacturers

8.4&nbsp;&nbsp;&nbsp; Contract research organization (CRO)

8.5&nbsp;&nbsp;&nbsp; Academics &amp; government research institutes

8.6&nbsp;&nbsp;&nbsp; Other end users

Chapter 9&nbsp;&nbsp;&nbsp;Clinical Trial Imaging Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; ICON PLC

10.2&nbsp;&nbsp;&nbsp; Medidata

10.3&nbsp;&nbsp;&nbsp; WCG Clinical

10.4&nbsp;&nbsp;&nbsp; Radiant Sage

10.5&nbsp;&nbsp;&nbsp; Biomedical Systems Corporation

10.6&nbsp;&nbsp;&nbsp; Biotelemetry, Inc.

10.7&nbsp;&nbsp;&nbsp; Image Core Lab

10.8&nbsp;&nbsp;&nbsp; WCG Clinical

10.9&nbsp;&nbsp;&nbsp; Ixico PLC

10.10&nbsp;&nbsp;&nbsp; Medspace Holdings Inc.

10.11&nbsp;&nbsp;&nbsp; Resonance Health Limited Median Technologies

10.12&nbsp;&nbsp;&nbsp; WorldCare Clinical

10.13&nbsp;&nbsp;&nbsp; Navitas Clinical Research, Inc 
&nbsp;

Clinical Trial Imaging Market

Inquiry Before Buying